Baseline clinical characteristics in CIE and non-CIE groupsa
CIE | Non-CIE | P Value | |
---|---|---|---|
No. of patients | 14 (3.5) | 382 (96) | |
Age (yr) | 73 [66–79] | 68 [57–75] | .054 |
Sex, female | 8 (57) | 254 (67) | .57 |
Body mass index (kg/m2) | 23.5 [21.4–26.3] | 22.9 [20.3–25.7] | .29 |
Race | |||
Asian | 14 (100) | 382 (100) | NA |
Medical history | |||
Hypertension | 10 (71) | 245 (64) | .78 |
Diabetes mellitus | 3 (21) | 35 (9.2) | .14 |
Hyperlipidemia | 6 (43) | 174 (46) | 1 |
Prior strokeb | 4 (29) | 45 (12) | .081 |
Ischemic stroke | 3 (21) | 17 (4.5) | |
Hemorrhagic stroke | 2 (14) | 28 (7.3) | |
Cerebral hemorrhage | 0 (0) | 6 (1.6) | |
SAH | 2 (14) | 22 (5.8) | |
Renal dysfunction (eGFR <45)c | 2 (14) | 19 (5.0) | .17 |
Hemodialysis | 2 (14) | 5 (1.3) | .022d |
eGFR, (mL/min per 1.73 m2) | 79.1 [55.5–92.2] | 79.9 [66.1–92.4] | .58 |
Smoking | 9 (64) | 155 (41) | .098 |
Drinking | 5 (36) | 146 (38) | 1 |
Allergye | 1 (7.1) | 82 (22) | .32 |
Allergy to contrast medium | 1 (7.1) | 20 (5.2) | .54 |
Note:—eGFR indicates estimated glomerular filtration rate; NA, not applicable.
↵a Unless otherwise indicated, values represent the number of aneurysms (%) or median [interquartile range]. Not all percentage totals reach 100% because of rounding.
↵b Patients with a history of both ischemic and hemorrhagic stroke were counted in each category.
↵c Renal dysfunction was defined as an eGFR of <45 mL/min/1.73 m2.
↵d P < .05.
↵e History of allergy included allergy to any food or drug.